Cito Remedies Private Limited
About Cito Remedies Private Limited
Data last updated:
Cito Remedies Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 June 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U51909KA2010PTC053969. Its GSTIN is 29AAECC0238M1ZJ (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Mysore Sreekantiah Shivani and Umadevi Puttaswamygowda Daniharry.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 167/F 1 2nd Cross Canara Bank Colony Nagarabhavi Bangalore South, Karnataka, India – 560072.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.38 Lakh, a decline of 90% compared to the previous year. For the same year it recorded a net loss of ₹4.03 Lakh (net margin -291%) and EBITDA of -₹3.9 Lakh (EBITDA margin -282.1%). Revenue has declined at a compounded annual rate (CAGR) of 67% over three years and 54% over five years.
As per MCA filings, the company has open charges of ₹24 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cito Remedies Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address167/F 1 2nd Cross Canara Bank Colony Nagarabhavi Bangalore South, Karnataka, India – 560072
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cito Remedies Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cito Remedies is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Cito Remedies Private Limited, buy the company report.
Financials of Cito Remedies Private Limited
FY 2025 filings availableCito Remedies Private Limited reported revenue of ₹1.38 Lakh (down 90% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 54% over five years, including a 90% fall in the latest year. EBITDA rose 76% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.9 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.03 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -282.1% | ||||
| Net Profit Margin | -291% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cito Remedies Private Limited, buy the company report.
Board of directors of Cito Remedies Private Limited
Cito Remedies has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mysore Sreekantiah Shivani | Director | 07 Jun 2010 | 16 Years 5 Months | Current |
| Umadevi Puttaswamygowda Daniharry | Director | 14 Jun 2019 | 7 Years 4 Months | Current |
| Shravanabelagola Nanjundaiah Sreekantaiah | Director | 07 Jun 2010 | 16 Years 5 Months | Current |
Auditor
Cito Remedies Private Limited is audited by DIVAKARA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DIVAKARA & ASSOCIATES | FY 2018 | 000763S |
Shareholding
The shareholding of Cito Remedies Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Cito Remedies Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Oct 2010 | 10250628 | State Bank of India | ₹24 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cito Remedies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cito Remedies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cito Remedies has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAECC0238M1ZJ | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cito Remedies Private Limited, buy the company report.
Recent activity
Cito Remedies Private Limited has 4 board changes on record since 2010: 3 appointments and 1 cessation. The latest: Umadevi Puttaswamygowda Daniharry ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Cito Remedies is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 June 2010 (16+ years old) and is registered under CIN U51909KA2010PTC053969.
Cito Remedies has 3 current directors:
- Mysore Sreekantiah Shivani - Director
- Umadevi Puttaswamygowda Daniharry - Director
- Shravanabelagola Nanjundaiah Sreekantaiah - Director
The latest financial statements of Cito Remedies on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cito Remedies is 29AAECC0238M1ZJ, registered in Karnataka.
The CIN (Corporate Identification Number) of Cito Remedies is U51909KA2010PTC053969. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cito Remedies was incorporated on 07 June 2010, making it 16+ years old. It is registered with the Registrar of Companies, Bangalore.
Umadevi Puttaswamygowda Daniharry ceased to be Additional Director on 30 Sep 2019. Umadevi Puttaswamygowda Daniharry was appointed as Director on 14 Jun 2019. Mysore Sreekantiah Shivani was appointed as Director on 07 Jun 2010. Cito Remedies has 4 board changes on record in total.
The registered office of Cito Remedies is at 167F 1 2nd Cross Canara Bank Colony Nagarabhavi Bangalore South, Karnataka, India – 560072.
Cito Remedies operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Cito Remedies has open charges of ₹24 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
